Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 15, 2015 01:35 ET | Source: Evotec AG

Evotec Achieves Further Milestones in TargetAD Collaboration With Janssen

HAMBURG, Germany, Jan. 15, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced the achievement of several small, but very important milestones in its...
January 07, 2015 01:37 ET | Source: Evotec AG

Evotec and Padlock Therapeutics Announce Initial Success and Extension of Long-Term Collaboration

HAMBURG, Germany, Jan. 7, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) and Padlock Therapeutics, Inc. ("Padlock") announced today that they have successfully...
December 22, 2014 01:42 ET | Source: Evotec AG

Evotec and Ohio State to Collaborate on Novel Cancer Therapy

Collaboration leverages the breadth & experience of Evotec's drug discovery infrastructure Efforts will explore the use of a novel approach, discovered at Ohio State, for targeting mutant...
December 18, 2014 11:36 ET | Source: Evotec AG

Achievement of Multiple Milestones in Evotec's Drug Discovery Alliances

HAMBURG, Germany, Dec. 18, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) disclosed today that it achieved multiple milestones in ongoing alliances with its strategic...
December 02, 2014 12:42 ET | Source: Evotec AG

Evotec and Sanofi Enter Into Exclusive Negotiations for a Major Multi-Component Strategic Collaboration

Parties have entered into exclusive negotiations and expect to sign the transaction in H1 2015 Goal to improve innovation effectiveness in drug discovery and pre-clinical...
November 12, 2014 01:57 ET | Source: Evotec AG

Evotec Reports Results of the First Nine Months of 2014

STRONG OPERATIONAL PERFORMANCE, POSITIVE EBITDA UNIQUE STRATEGIC POSITION DESPITE RECENT DIAPEP277® SETBACK IMPORTANT MILESTONES EXPECTED FOR Q4 VERY STRONG CASH...
November 05, 2014 06:59 ET | Source: Evotec AG

Evotec to Report Results for the First Nine Months of 2014 on 12 November 2014

HAMBURG, Germany, Nov. 5, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first nine months of 2014 on Wednesday, 12 November...
September 30, 2014 01:38 ET | Source: Evotec AG

Evotec Receives Milestone as Part of Its Multi-Target Alliance With Bayer HealthCare

HAMBURG, Germany, Sept. 30, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that its multi-target collaboration with Bayer HealthCare ("Bayer") has...
September 24, 2014 01:34 ET | Source: Evotec AG

Evotec and Its Partners Awarded Public Grants to Develop New Drug Candidates to Treat Multiple Sclerosis

HAMBURG, Germany, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today that it has entered into three novel research projects for the treatment of...
September 18, 2014 01:35 ET | Source: Evotec AG

Evotec Takes Legal Steps Against Andromeda Biotech, Ltd.

HAMBURG, Germany, Sept. 18, 2014 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) announced today after careful evaluation that it will take legal steps against Israel-based...